Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
•
General Neurology
How can we minimize the risk of overinterpreting reactive findings from repeat lumbar punctures?
e.g. reactive pleiocytosis, in light of publication from
Schimdauer et al in Eur J Neurol 2025 Apr
Related Questions
At what degree of lymphopenia do you switch/discontinue dimethyl fumarate in patients with multiple sclerosis?
When should patients be referred for advanced MRI testing to assess for CVS and PRL?
How do you handle medication management for patients on immunosuppressive therapy who are lost to follow-up?
What are red flags in an evaluation for possible multiple sclerosis that should prompt workup for genetic/inherited conditions?
When do you consider disease modifying therapy in radiographically isolated syndrome?
What are your preferred treatments for relapsing remitting multiple sclerosis with comorbid IBD?
when do you treat suspected autoimmune encephalitis before antibody results?
In a patient with strong serologic evidence of SLE presenting with isolated bilateral lower limb sensorimotor neuropathy, normal neuroimaging, and CSF, would you initiate cyclophosphamide with pulse-dose steroids upfront, or reserve escalation (e.g., plasma exchange or immunosuppressants) for cases refractory to steroids?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
How do you determine if generic vs brand formulation of a DMT is the probable cause of worsening multiple sclerosis disease activity?